论文部分内容阅读
作者对本院10年中所收治的扩张型原发性心肌病患者进行随访分析。118例中首次住院死亡12例,余106例中91例得到随诊,随诊率85.8％。随诊时间2月～10年(平均2.9年)。用寿命表法计算生存率为:1年85.25％,2年67％,5年43.7％,10年25.5％。提示本病预后凶险。年龄、心脏大个、心功能是影响预后的重要因素。严重及复杂的心律失常对无心衰患者,可使预后恶化,早期治疗及长期服用扩血管药消心痛可使预后改善。激素治疗对远期预后无关。
The author of our hospital for 10 years in patients with dilated primary cardiomyopathy were followed up analysis. Of the 118 patients, 12 were hospitalized for the first time, and 91 of the remaining 106 patients were followed up, with a follow-up rate of 85.8%. Follow-up time of 2 months to 10 years (mean 2.9 years). Survival rates were calculated using the life table method: 85.25% for 1 year, 67% for 2 years, 43.7% for 5 years and 25.5% for 10 years. Prompt prognosis of the disease dangerous. Age, heart, heart function is an important factor affecting the prognosis. Serious and complex arrhythmias in patients without heart failure, can make the prognosis worse, early treatment and long-term use of vasodilators and heartburn pain relief can improve the prognosis. Hormone therapy has nothing to do with long-term prognosis.